Am J Perinatol 2021; 38(02): 099-104
DOI: 10.1055/s-0040-1713927
SMFM Fellowship Series Article

Maternal Outcomes of Ongoing Pregnancies Complicated by Fetal Life-Limiting Conditions

Talia Coney
1   Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, Wisconsin
,
Rachel Russell
1   Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, Wisconsin
,
Steven R. Leuthner
2   Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin
,
1   Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, Wisconsin
3   Center for Advancing Population Science, Medical College of Wisconsin, Milwaukee, Wisconsin
› Author Affiliations
Funding None.

Abstract

Objective This study aimed to examine maternal outcomes of ongoing pregnancies complicated by fetal life-limiting conditions.

Study design This was a retrospective matched cohort study of women with a diagnosis of fetal life-limiting condition between 2010 and 2018 in a single academic center. Cases were matched to controls (women who had normal fetal anatomic survey) according to year of delivery, body mass index, and parity in a 1:4 ratio. Bivariable and multivariable analyses were performed to compare the prevalence of the primary composite outcome, which included any one of the following: preeclampsia, gestational diabetes, cesarean delivery, third and fourth degree laceration, postpartum hemorrhage, blood transfusion, endometritis or wound infection, maternal intensive care unit admission, hysterectomy and maternal death, between cases and controls.

Results During the study period, we found 101 cases that met inclusion criteria, matched to 404 controls. The rate of the composite maternal outcome did not differ between the two groups (39.6 vs. 38.9%, p = 0.948). For individual outcomes, women with diagnosis of fetal life-limiting condition had higher rates of blood transfusion (2.0 vs. 0%, p = 0.005) and longer length of the first stage of labor (median of 12 [6.8–22.0] hours vs. 6.6 [3.9–11.0] hours; p < 0.001). In a multivariable analysis, first stage of labor continued to be longer by an average of 6.48 hours among women with a diagnosis of fetal life-limiting condition compared with controls.

Conclusion After controlling for confounding factors, except a longer first stage of labor, women diagnosed with fetal life-limiting conditions who continued the pregnancy did not have a higher rate of adverse maternal outcomes.

Key Points

  • The rates of ongoing pregnancies with fetal life-limiting conditions are increasing.

  • Women with ongoing pregnancies with fetal life-limiting conditions had longer first stage of labor.

  • The rest of the adverse maternal outcomes were not increased in this obstetric population.

Note

This study was presented in the poster format at the 40th annual meeting of the Society for Maternal–Fetal Medicine, Grapevine, TX, February 5 to 8, 2020.




Publication History

Received: 29 March 2020

Accepted: 02 June 2020

Article published online:
09 July 2020

© 2020. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Wilkinson D, de Crespigny L, Xafis V. Ethical language and decision-making for prenatally diagnosed lethal malformations. Semin Fetal Neonatal Med 2014; 19 (05) 306-311
  • 2 Breeze AC, Lees CC. Antenatal diagnosis and management of life-limiting conditions. Semin Fetal Neonatal Med 2013; 18 (02) 68-75
  • 3 Leuthner SR, Acharya K. Perinatal counseling following a diagnosis of trisomy 13 or 18: incorporating the facts, parental values, and maintaining choices. Adv Neonatal Care 2020; 20 (03) 204-215
  • 4 Munson D, Leuthner SR. Palliative care for the family carrying a fetus with a life-limiting diagnosis. Pediatr Clin North Am 2007; 54 (05) 787-798 , xii xii
  • 5 Kilby MD, Pretlove SJ, Bedford Russell AR. Multidisciplinary palliative care in unborn and newborn babies. BMJ 2011; 342: d1808
  • 6 Dotters-Katz SK, Kuller JA, Grace MR, Laifer SA, Strauss RA. Management considerations for ongoing pregnancies complicated by trisomy 13 and 18. Obstet Gynecol Surv 2016; 71 (05) 295-300
  • 7 Cortezzo DE, Bowers K, Cameron Meyer M. Birth planning in uncertain or life-limiting fetal diagnoses: perspectives of physicians and parents. J Palliat Med 2019; 22 (11) 1337-1345
  • 8 Silasi M, Rana S, Powe C. et al. Placental expression of angiogenic factors in trisomy 13. Am J Obstet Gynecol 2011; 204 (06) 546.e1-546.e4
  • 9 Houlihan OA, O'Donoghue K. The natural history of pregnancies with a diagnosis of trisomy 18 or trisomy 13; a retrospective case series. BMC Pregnancy Childbirth 2013; 13: 209
  • 10 Dotters-Katz SK, Senz KL, Humphrey WM, Lee VR, Caughey AB. Trisomy 18 pregnancies: is there an increased maternal risk?. Am J Perinatol 2017; 34 (11) 1054-1057
  • 11 Tuohy JF, James DK. Pre-eclampsia and trisomy 13. Br J Obstet Gynaecol 1992; 99 (11) 891-894
  • 12 Al-Obaidly S, Thomas J, Abu Jubara M. et al. Anencephaly and obstetric outcome beyond the age of viability. J Perinat Med 2018; 46 (08) 885-888
  • 13 Ekmekci E, Gencdal S. What's happening when the pregnancies are not terminated in case of anencephalic fetuses?. J Clin Med Res 2019; 11 (05) 332-336
  • 14 Walsh CA, MacTiernan A, Farrell S. et al. Mode of delivery in pregnancies complicated by major fetal congenital heart disease: a retrospective cohort study. J Perinatol 2014; 34 (12) 901-905
  • 15 Guttmacher Institute. Accessed March 26, 2020 at: https://www.guttmacher.org/article/2019/07/state-policy-trends-mid-year-2019-states-race-ban-or-protect-abortion
  • 16 Parravicini E, Lorenz JM. Neonatal outcomes of fetuses diagnosed with life-limiting conditions when individualized comfort measures are proposed. J Perinatol 2014; 34 (06) 483-487
  • 17 Chervenak FA, McCullough LB. The professional responsibility model and patient requests for nonindicated early delivery. Virtual Mentor 2014; 16 (10) 793-796
  • 18 Winn P, Acharya K, Peterson E, Leuthner S. Prenatal counseling and parental decision-making following a fetal diagnosis of trisomy 13 or 18. J Perinatol 2018; 38 (07) 788-796
  • 19 Wolter A, Nosbüsch S, Kawecki A. et al. Prenatal diagnosis of functionally univentricular heart, associations and perinatal outcomes. Prenat Diagn 2016; 36 (06) 545-554
  • 20 Galindo A, Nieto O, Villagrá S, Grañeras A, Herraiz I, Mendoza A. Hypoplastic left heart syndrome diagnosed in fetal life: associated findings, pregnancy outcome and results of palliative surgery. Ultrasound Obstet Gynecol 2009; 33 (05) 560-566
  • 21 Beroukhim RS, Gauvreau K, Benavidez OJ, Baird CW, LaFranchi T, Tworetzky W. Perinatal outcome after prenatal diagnosis of single-ventricle cardiac defects. Ultrasound Obstet Gynecol 2015; 45 (06) 657-663
  • 22 Liu MY, Zielonka B, Snarr BS, Zhang X, Gaynor JW, Rychik J. Longitudinal assessment of outcome from prenatal diagnosis through fontan operation for over 500 fetuses with single ventricle-type congenital heart disease: the philadelphia fetus-to-fontan cohort study. J Am Heart Assoc 2018; 7 (19) e009145
  • 23 McCormick AC, McIntosh JJ, Gao W, Hibbard JU, Cruz MO. The impact of fetal anomalies on contemporary labor patterns. Am J Perinatol 2019; 36 (14) 1423-1430
  • 24 Wacholder S, Silverman DT, McLaughlin JK, Mandel JS. Selection of controls in case-control studies. III. Design options. Am J Epidemiol 1992; 135 (09) 1042-1050